Meeting Details

Schedule/Additional Infoexpand_more
Optimizing Diabetes Care With GLP-1 Receptor Agonists
October 5, 2022
2:00 PM - 3:00 PM
A patient-centered approach that takes into consideration both treatment-related and patient-specific factors should be used when selecting pharmacologic treatment for diabetes. With updated ADA guidance around use of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) in patients with ASCVD and CKD, you’ve likely seen more and more of the GLP-1RAs currently approved. During this webinar, two experts in the field will review everything you need to know about the GLP-1RAs including their pharmacology, glycemic effects, safety concerns and place in therapy.
  • List Price: Free